Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

IoM chaparral monograph

This article was originally published in The Tan Sheet

Executive Summary

Institute of Medicine will meet Aug. 30-31 to discuss its chaparral draft monograph, the first prototype monograph developed as part of institute's Proposed Framework for Evaluating the Safety of Dietary Supplements. Under the framework, monographs will be prepared on supplements selected for safety review to help guide further FDA action ("1The Tan Sheet" July 29, 2002, p. 4). The 2chaparral monograph, which does not reach safety conclusions, will be discussed in public session the afternoon of Aug. 30. Written comments will be accepted...
Advertisement

Related Content

Topics

Advertisement
UsernamePublicRestriction

Register

PS094448

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel